BG105345A - Tpl-2/cot kinase and methods of use - Google Patents

Tpl-2/cot kinase and methods of use

Info

Publication number
BG105345A
BG105345A BG105345A BG10534501A BG105345A BG 105345 A BG105345 A BG 105345A BG 105345 A BG105345 A BG 105345A BG 10534501 A BG10534501 A BG 10534501A BG 105345 A BG105345 A BG 105345A
Authority
BG
Bulgaria
Prior art keywords
tpl
methods
nfkb
activation
cot kinase
Prior art date
Application number
BG105345A
Other languages
Bulgarian (bg)
English (en)
Inventor
Hamish ALLEN
Richard Dixon
Joanne KAMENS
Dineli Wickramasinghe
Yajun Xu
Monica BELICH
Leland JOHNSTON
Steven LEY
Andres Salmeron
Original Assignee
BASF AKTIENGESELLSCHAFT (US) c/o BASF BIORESEARCHCORP.,
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9817930.2A external-priority patent/GB9817930D0/en
Priority claimed from GBGB9827712.2A external-priority patent/GB9827712D0/en
Application filed by BASF AKTIENGESELLSCHAFT (US) c/o BASF BIORESEARCHCORP.,, Medical Research Council filed Critical BASF AKTIENGESELLSCHAFT (US) c/o BASF BIORESEARCHCORP.,
Publication of BG105345A publication Critical patent/BG105345A/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
BG105345A 1998-08-18 2001-03-15 Tpl-2/cot kinase and methods of use BG105345A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9817930.2A GB9817930D0 (en) 1998-08-18 1998-08-18 Pathway
GBGB9827712.2A GB9827712D0 (en) 1998-12-16 1998-12-16 Pathway
PCT/US1999/018543 WO2000011191A2 (en) 1998-08-18 1999-08-13 Tpl-2/cot kinase and methods of use

Publications (1)

Publication Number Publication Date
BG105345A true BG105345A (en) 2001-12-31

Family

ID=26314223

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105345A BG105345A (en) 1998-08-18 2001-03-15 Tpl-2/cot kinase and methods of use

Country Status (22)

Country Link
US (1) US20020099169A1 (xx)
EP (1) EP1105501A2 (xx)
JP (1) JP4719831B2 (xx)
KR (1) KR20010085407A (xx)
CN (1) CN1323346A (xx)
AU (1) AU767973B2 (xx)
BG (1) BG105345A (xx)
BR (1) BR9913070A (xx)
CA (1) CA2339036A1 (xx)
CZ (1) CZ2001625A3 (xx)
HK (1) HK1041901A1 (xx)
HU (1) HUP0103797A2 (xx)
ID (1) ID28955A (xx)
IL (1) IL141355A0 (xx)
MX (1) MXPA01001747A (xx)
NO (1) NO20010786L (xx)
NZ (1) NZ510313A (xx)
PL (1) PL347137A1 (xx)
RU (1) RU2001107122A (xx)
SK (1) SK2242001A3 (xx)
TR (2) TR200103840T2 (xx)
WO (1) WO2000011191A2 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660906B1 (en) 2000-03-08 2003-12-09 Thomas Jefferson University Tpl2 transgenic knockout mice
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
GB0402661D0 (en) * 2004-02-06 2004-03-10 Medical Res Council TPL2 and its expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514505A (en) * 1995-05-15 1996-05-07 Xerox Corporation Method for obtaining improved image contrast in migration imaging members
UA71889C2 (uk) * 1996-04-02 2005-01-17 Йєда Рісерч Енд Дівелопмент Ко. Лтд. Модулятори зв'язаного з рецептором tnf фактора (traf), їх одержання та застосування

Also Published As

Publication number Publication date
CZ2001625A3 (cs) 2002-02-13
HK1041901A1 (zh) 2002-07-26
KR20010085407A (ko) 2001-09-07
EP1105501A2 (en) 2001-06-13
MXPA01001747A (es) 2003-06-06
CA2339036A1 (en) 2000-03-02
IL141355A0 (en) 2002-03-10
ID28955A (id) 2001-07-19
BR9913070A (pt) 2001-05-08
US20020099169A1 (en) 2002-07-25
TR200103840T2 (tr) 2002-06-21
WO2000011191A2 (en) 2000-03-02
RU2001107122A (ru) 2003-04-20
CN1323346A (zh) 2001-11-21
AU767973B2 (en) 2003-11-27
WO2000011191A3 (en) 2000-06-08
PL347137A1 (en) 2002-03-25
NO20010786D0 (no) 2001-02-16
TR200100624T2 (tr) 2001-08-21
JP4719831B2 (ja) 2011-07-06
AU5563399A (en) 2000-03-14
NO20010786L (no) 2001-04-17
HUP0103797A2 (hu) 2003-10-28
SK2242001A3 (en) 2001-10-08
JP2002531058A (ja) 2002-09-24
NZ510313A (en) 2003-11-28

Similar Documents

Publication Publication Date Title
IL192337A0 (en) NOVEL 2,4,8-TRISUBSTITUTED-8h- PYRIDO[2,3-d]PYRIMIDIN-7-ONE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, PROCESSES
PL339860A1 (en) Methods of modulating the action of serine/threonine protein kinase by means of compounds based on 5-azaquinoxaline
NZ517758A (en) Pyrazolopyrimidines useful as therapeutic agents
AR004717A1 (es) Sal de bis-indolilmaleimida, formulacion farmaceutica que la comprende y su uso para la fabricacion de dicha formulacion
WO2002030353A3 (en) NF-λB INHIBITORS
ES2180899T3 (es) Dihidrato d de olanzapina.
NO20011356D0 (no) Pyrrolopyrimidiner som proteinkinase-inhibitorer
IL119963A (en) Spring diaphragm for shut-off valves and regulators
DE69817677D1 (de) Solenoid für Magnetventil
BG105361A (en) Genes of the 1-desoxy-d-xylulose biosynthetic pathway
PL371180A1 (en) Pyrimidotriazines as phosphatase inhibitors
AU8330898A (en) Substituted heterocycles and their use in medicaments
BG105345A (en) Tpl-2/cot kinase and methods of use
PT977716E (pt) Utilizacao de alcoois como aditivos para rebocos e/ou argamassas
TR199900505T2 (xx)
AU4388296A (en) Nuclear protein serine/threonine kinases
BR0114677A (pt) Inibição da dependência de fator de crescimento de células de tumores
CA96911S (en) Cartridge for an air freshener
ATE331172T1 (de) Eletromagnetisches vorgesteuertes membranventil für sanitäre einrichtungen
AU1278500A (en) Use of nicergoline for treating spasmodism
AU2576901A (en) Agents and methods for the treatment of proliferative diseases
AU2001294033A1 (en) Methods for treating disorders of the female reproductive system
IL155800A (en) Nucleic acid sequences encoding human testis specific kinases
BR9600648A (pt) Carcaça para integração de válvula termostática
BR8900189A (pt) Jogo de valvulas para compressor de embolo